These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 23964630)

  • 1. COPD updates: what's new in pathophysiology and management?
    Noujeim C; Bou-Khalil P
    Expert Rev Respir Med; 2013 Aug; 7(4):429-37. PubMed ID: 23964630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Issues in pulmonary function testing for the screening and diagnosis of chronic obstructive pulmonary disease.
    Lam DC; Hui CK; Ip MS
    Curr Opin Pulm Med; 2012 Mar; 18(2):104-11. PubMed ID: 22262139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How can we define well-controlled chronic obstructive pulmonary disease?
    Molina París J
    Expert Rev Respir Med; 2013 Apr; 7(2 Suppl):3-15. PubMed ID: 23551019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes and markers in the assessment of chronic obstructive pulmonary disease.
    Jones PW; Agusti AG
    Eur Respir J; 2006 Apr; 27(4):822-32. PubMed ID: 16585091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Updates in the management of stable chronic obstructive pulmonary disease.
    Narsingam S; Bozarth AL; Abdeljalil A
    Postgrad Med; 2015; 127(7):758-70. PubMed ID: 26330087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review of the GOLD guidelines for the diagnosis and treatment of patients with COPD.
    Fromer L; Cooper CB
    Int J Clin Pract; 2008 Aug; 62(8):1219-36. PubMed ID: 18547365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The 2011 revision of the global strategy for the diagnosis, management and prevention of COPD (GOLD)--why and what?
    Vestbo J; Hurd SS; Rodriguez-Roisin R
    Clin Respir J; 2012 Oct; 6(4):208-14. PubMed ID: 22906068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Future perspectives in COPD.
    Celli B; Goldstein R; Jardim J; Knobil K
    Respir Med; 2005 Dec; 99 Suppl B():S41-8. PubMed ID: 16256325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic obstructive pulmonary disease outcome measurements: what's important? What's useful?
    Gross NJ
    Proc Am Thorac Soc; 2005; 2(4):267-71; discussion 290-1. PubMed ID: 16267347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Which pulmonary function tests best differentiate between COPD phenotypes?
    Salzman SH
    Respir Care; 2012 Jan; 57(1):50-57; discussion 58-60. PubMed ID: 22222125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What is in the guidelines about the pharmacological treatment of chronic obstructive pulmonary disease?
    López-Campos JL; Calero Acuña C
    Expert Rev Respir Med; 2013 Apr; 7(2 Suppl):43-51. PubMed ID: 23551023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The progression of chronic obstructive pulmonary disease is heterogeneous: the experience of the BODE cohort.
    Casanova C; de Torres JP; Aguirre-Jaíme A; Pinto-Plata V; Marin JM; Cordoba E; Baz R; Cote C; Celli BR
    Am J Respir Crit Care Med; 2011 Nov; 184(9):1015-21. PubMed ID: 21836135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacological treatment of COPD. Where are we now?].
    Calle Rubio M; Pinedo Sierra C; Rodríguez Hermosa JL
    Arch Bronconeumol; 2010 Dec; 46 Suppl 10():3-7. PubMed ID: 21316549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic obstructive pulmonary disease diagnosis: the simpler the better? Not always.
    Di Marco F; Tantucci C; Pellegrino G; Centanni S
    Eur J Intern Med; 2013 Apr; 24(3):199-202. PubMed ID: 23466208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monitoring of patients with COPD: a review of current guidelines' recommendations.
    van den Bemt L; Schermer T; Smeele I; Bischoff E; Jacobs A; Grol R; van Weel C
    Respir Med; 2008 May; 102(5):633-41. PubMed ID: 18242067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Exercise tolerance in patients with chronic obstructive pulmonary disease].
    Chlumský J
    Cas Lek Cesk; 2005; 144(6):372-6. PubMed ID: 16047838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of undiagnosed and undertreated chronic obstructive pulmonary disease in lung cancer population.
    Zhang J; Zhou JB; Lin XF; Wang Q; Bai CX; Hong QY
    Respirology; 2013 Feb; 18(2):297-302. PubMed ID: 23051099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The concept of control of COPD in clinical practice.
    Soler-Cataluña JJ; Alcázar-Navarrete B; Miravitlles M
    Int J Chron Obstruct Pulmon Dis; 2014; 9():1397-405. PubMed ID: 25548521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of chronic obstructive pulmonary disease according to BTS, ERS, GOLD and ATS criteria in relation to doctor's diagnosis, symptoms, age, gender, and smoking habits.
    Lindberg A; Jonsson AC; Rönmark E; Lundgren R; Larsson LG; Lundbäck B
    Respiration; 2005; 72(5):471-9. PubMed ID: 16210885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Stage and prognosis of COPD].
    Akashiba T
    Nihon Rinsho; 2003 Dec; 61(12):2089-93. PubMed ID: 14674315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.